AstraZeneca AZN reported strong U.S. phase 3 data for its COVID-19 vaccine, AZD1222. We don't expect any changes to our fair value estimate based on the favorable data, however, since the firm plans ...
FRANKFURT (Reuters) - Germany's influential vaccine advisory panel said on Thursday all infants in the country should receive AstraZeneca and Sanofi's antibody therapy to protect them against the ...
FRANKFURT (Reuters) – A study of side effects following vaccination with AstraZeneca’s anti-COVID-19 shot in Scotland found only an association with a largely harmless bleeding condition and no link ...
The Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. However, on May 7 2024, the European Commission announced the vaccine is no longer authorised for use. The first ...
The sister of a man who died from a blood clot after receiving AstraZeneca's COVID-19 vaccine is encouraging people to continue taking it. Alison Astles told The Daily Telegraph that her family still ...
Rebecca Stevens received an AstraZeneca Covid vaccine in April 2021 and died in October last year at the age of 48 Mr Stevens said that his wife, the mother of two grown-up sons, had gone from being a ...
European regulators are set to start an accelerated review of a Covid-19 vaccine front-runner from the University of Oxford and AstraZeneca Plc, according to a person with knowledge of the situation, ...
It marks a partial U-turn after the drugs giant, Britain's biggest listed company, put a plan to spend £200m on its Cambridge site on pause last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results